S
Sue C. Kaste
Researcher at St. Jude Children's Research Hospital
Publications - 293
Citations - 12192
Sue C. Kaste is an academic researcher from St. Jude Children's Research Hospital. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 54, co-authored 285 publications receiving 10775 citations. Previous affiliations of Sue C. Kaste include RMIT University & University of Memphis.
Papers
More filters
Journal ArticleDOI
Treating childhood acute lymphoblastic leukemia without cranial irradiation.
Ching-Hon Pui,Dario Campana,Deqing Pei,W. Paul Bowman,John T. Sandlund,Sue C. Kaste,Raul C. Ribeiro,Jeffrey E. Rubnitz,Susana C. Raimondi,Mihaela Onciu,Elaine Coustan-Smith,Larry E. Kun,Sima Jeha,Cheng Cheng,Scott C. Howard,Vickey Simmons,Amy Bayles,Monika L. Metzger,James M. Boyett,Wing Leung,Rupert Handgretinger,James R. Downing,William E. Evans,Mary V. Relling +23 more
TL;DR: With effective risk-adjusted chemotherapy, prophylactic cranial irradiation can be safely omitted from the treatment of childhood ALL.
A Report From the Childhood Cancer Survivor Study
Carmen L. Wilson,Kimberley Dilley,Kirsten K. Ness,W. Leisenring,Charles A. Sklar,Sue C. Kaste,Marilyn Stovall,Daniel M. Green,Gregory T. Armstrong,Leslie L. Robison,Nina S. Kadan-Lottick +10 more
TL;DR: Findings from this study indicated that the prevalence of fractures among adult survivors did not increase compared with that of siblings, and additional studies of bone health among aging female cancer survivors may be warranted.
Journal ArticleDOI
The Image Gently campaign: working together to change practice.
Marilyn J. Goske,Kimberly E. Applegate,Jennifer Boylan,Priscilla F. Butler,Michael J. Callahan,Brian D. Coley,Shawn Farley,Donald P. Frush,Marta Hernanz-Schulman,Diego Jaramillo,Neil D. Johnson,Sue C. Kaste,Greg Morrison,Keith J. Strauss,Nora Tuggle +14 more
Journal ArticleDOI
Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog–Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032
Giles W. Robinson,Brent A. Orr,Gang Wu,Sridharan Gururangan,Tong Lin,Ibrahim Qaddoumi,Roger J. Packer,Stewart Goldman,Michael D. Prados,Annick Desjardins,Murali Chintagumpala,Naoko Takebe,Sue C. Kaste,Michael Rusch,Sariah Allen,Arzu Onar-Thomas,Clinton F. Stewart,Maryam Fouladi,James M. Boyett,Richard J. Gilbertson,Tom Curran,David W. Ellison,Amar Gajjar +22 more
TL;DR: Molecular analyses support the hypothesis that SMO inhibitor activity depends on the genomic aberrations within the tumor and should be advanced in SHH-MB studies.
Journal ArticleDOI
The Cyclophosphamide Equivalent Dose as an Approach for Quantifying Alkylating Agent Exposure. A Report from the Childhood Cancer Survivor Study
Daniel M. Green,Vikki G. Nolan,Pamela Goodman,John Whitton,Deo Kumar Srivastava,Wendy M. Leisenring,Joseph P. Neglia,Charles A. Sklar,Sue C. Kaste,Melissa M. Hudson,Lisa Diller,Marilyn Stovall,Sarah S. Donaldson,Leslie L. Robison +13 more
TL;DR: The widely used Alkylating Agent Dose (AAD) score is derived from the drug dose distribution of the study population and thus cannot be used for comparisons across populations as each will have a unique distribution of drug doses.